TrialLancet (London, England)2017

Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial.

David E Kandzari et al.PubMed ↗Publisher ↗

No numbers read from the abstract.